RYTM
Companies
NASDAQ
Rhythm Pharmaceuticals Inc.
Health Care
$61.48
+$6.00 (+10.72%)
Price Chart
Overview
About RYTM
rhythm pharmaceuticals inc. is a biotechnology company located in 855 boylston street, 11th floor, boston, ma, united states.
Market Cap
$2.4B
Volume
64.9M
Avg. Volume
44.9M
P/E Ratio
-21.621721
Dividend Yield
0.00%
Employees
212.0
Company Information
Latest News for RYTM
Rhythm Pharmaceuticals' Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential
December 20, 2024
Stifel's Paul Matteis says look for biotech names not dependent on the FDA amid sector uncertainty
March 31, 2025
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates
May 7, 2025
Risk & Correlation Analysis
Market Correlation
0.95
Moderate Correlation
Volatility
High (0.49)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, RYTM shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$2.4B
Volume64.9M
P/E Ratio-21.62
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 26, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025